Smith & Nephew (SNN) Income from Continuing Operations (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Income from Continuing Operations of 167000000.0 for Q4 2024, down 33.2% year-on-year from 250000000.0 in Q1 2024, and down 33.2% on a QoQ basis from 250000000.0 in Q4 2023.
Smith & Nephew (SNN) Income from Continuing Operations (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Income from Continuing Operations for 16 consecutive years, with 167000000.0 the latest figure, recorded in Q4 2024.
- Quarterly Income from Continuing Operations fell 33.2% year-over-year to 167000000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 889000000.0 (up 60.47% YoY) and the FY2025 annual result came in at 625000000.0, up 51.7% from the prior year.
- Income from Continuing Operations fell to 167000000.0 in Q4 2024 per SNN's latest filing, from 250000000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for SNN reached as high as 250000000.0 in Q4 2023 and fell as low as 168000000.0 in Q4 2020.
- A 5-year average of 144200000.0 and a median of 231000000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2020 — Income from Continuing Operations sank 131.94% — and 2021, when it jumped 243.45%.
- Year by year, Income from Continuing Operations stood at 168000000.0 in 2020, then soared by 243.45% to 241000000.0 in 2021, then declined by 4.15% to 231000000.0 in 2022, then grew by 8.23% to 250000000.0 in 2023, then sank by 33.2% to 167000000.0 in 2024.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 167000000.0, 250000000.0, and 231000000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 220.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 167.00 Mn |
| Dec 31, 2023 | 250.00 Mn |
| Dec 31, 2022 | 231.00 Mn |
| Dec 31, 2021 | 241.00 Mn |
| Dec 31, 2020 | -168.00 Mn |
| Dec 31, 2019 | 526.00 Mn |
| Dec 31, 2018 | 459.00 Mn |
| Dec 31, 2017 | 495.00 Mn |
| Dec 31, 2016 | 605.00 Mn |
| Dec 31, 2015 | 560.00 Mn |
| Dec 31, 2014 | 562.00 Mn |
| Sep 30, 2014 | 204.00 Mn |
| Mar 31, 2014 | 264.00 Mn |
| Dec 31, 2013 | 450.00 Mn |
| Mar 31, 2013 | 302.00 Mn |
| Dec 31, 2012 | 584.00 Mn |
| Jun 30, 2012 | 641.00 Mn |
| Mar 31, 2012 | 286.00 Mn |
| Dec 31, 2011 | 469.00 Mn |
| Sep 30, 2011 | 834.00 Mn |